| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 03/07/2012 | CN101797392B Palladium-103 and io-125 compound sealed seed source, source core and source core preparation method |
| 03/07/2012 | CA2714253A1 Directed radiotherapy |
| 03/06/2012 | US8129528 Method for the use of [11 C] carbon monoxide in labeling synthesis of 11C-labelled amides using metal amides and photo-induced free radical carbonylation |
| 03/06/2012 | US8129335 Method for automated, large-scale measurement of the molecular flux rates of the proteome or the organeome using mass spectrometry |
| 03/06/2012 | US8129121 Regulation of lipid droplet formation by modulation of FIT1 and FIT2 and uses thereof |
| 03/06/2012 | US8128906 Stabilized uncoated particles of reversed liquid crystalline phase materials |
| 03/06/2012 | US8128905 Stabilized uncoated particles of reversed liquid crystalline phase materials |
| 03/01/2012 | WO2012027570A2 Dual variable domain immunoglobulins and uses thereof |
| 03/01/2012 | WO2012025464A1 Fluorodeuteriomethyl tyrosine derivatives |
| 03/01/2012 | US20120053163 Steroids as Agonists for FXR |
| 03/01/2012 | US20120052479 Methods, compositions and devices for inducing stasis in tissues and organs |
| 03/01/2012 | US20120052010 Imaging tumor perfusion, oxidative metabolism using dynamic ace pet in patients with head and neck cancer during radiotherapy |
| 03/01/2012 | US20120052009 Imaging probes, methods of making imaging probes, and methods of imaging |
| 03/01/2012 | US20120052008 Nanostructures comprising radioisotopes and/or metals |
| 03/01/2012 | US20120052007 Peripheral blood sparc binding antibodies and uses thereof |
| 03/01/2012 | US20120052006 Gold/lanthanide nanoparticle conjugates and uses thereof |
| 03/01/2012 | US20120052005 Combination therapy to improve drug efficiency |
| 03/01/2012 | US20120052004 Carbon nanotube based magnetic resonance image contrast agents |
| 03/01/2012 | US20120052003 Microorganisms for preventing and treating neoplasms accompanying cellular therapy |
| 03/01/2012 | CA2809433A1 Dual variable domain immunoglobulins and uses thereof |
| 03/01/2012 | CA2714205A1 Method of radiolabeling |
| 02/28/2012 | US8124725 PDGF-Rβ binders |
| 02/28/2012 | US8124620 3-Substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
| 02/28/2012 | US8124619 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
| 02/28/2012 | US8124618 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
| 02/28/2012 | US8124054 Chelating agent conjugated α-MSH peptide derivatives, preparation method thereof and composition for diagnosis and treatment of melanoma comprising the same as an active ingredient |
| 02/28/2012 | US8124052 for drug screening antitumor angents; genetic engineering; microarrays; kits |
| 02/28/2012 | US8124050 Method for coating the internal surface of a reaction vessel |
| 02/28/2012 | CA2353468C Radioconjugation of internalizing antibodies |
| 02/23/2012 | WO2012024604A2 High-valent palladium fluoride complexes and uses thereof |
| 02/23/2012 | WO2012024196A2 A novel method for creating, suspending and stabilizing electronically modified reaction intermideates |
| 02/23/2012 | WO2012022932A1 Process for producing radiohalogenated bioconjugates and products thereof |
| 02/23/2012 | WO2012022812A1 Imaging tuberculosis with pyrazinamide contrast agents |
| 02/23/2012 | WO2012022676A1 Peptide radiotracer compositions |
| 02/23/2012 | US20120045394 Human and mouse targeting peptides identified by phage display |
| 02/23/2012 | US20120045393 Lhrh-ii peptide analogs |
| 02/23/2012 | US20120045392 Pyro-glutamate a beta targeting agents |
| 02/23/2012 | US20120045391 Formulations Targeting IGFBP7 for Diagnosis and Therapy of Cancer |
| 02/23/2012 | US20120045390 Composition and Methods for the Diagnosis and Treatment of Tumor |
| 02/23/2012 | US20120045389 Methods and reagents for efficient and targeted gene transfer to monocytes and macrophages |
| 02/23/2012 | CA2844109A1 Compositions and methods to inhibit stem cell and progenitor cell binding to lymphoid tissue and for regenerating germinal centers in lymphatic tissues |
| 02/23/2012 | CA2807491A1 Peptide radiotracer compositions |
| 02/22/2012 | EP2419440A1 Peptide ligands for clusterin and uses thereof |
| 02/22/2012 | EP2419142A2 Pretargeting kit, method and agents used therein |
| 02/22/2012 | EP2419141A1 Pretargeting kit, method and agents used therein |
| 02/22/2012 | EP2419096A2 Stabilization of radiopharmaceutical compositions using ascorbic acid |
| 02/22/2012 | CN102358752A GLP-1 and exendin related invention |
| 02/22/2012 | CN102358468A Kit for preparing positron medicine <18>F-FLT |
| 02/22/2012 | CN101648899B PET显像剂L-5-<sup>18</sup>FETP的合成方法 PET imaging agent L-5- synthesis method <sup> 18 </ sup> FETP's |
| 02/22/2012 | CN101003526B 茋衍生物及其用于结合和成像淀粉样蛋白斑的用途 Stilbene derivatives and their use for binding and imaging amyloid plaques |
| 02/21/2012 | US8119689 Adjuvants on the basis of bisacyloxypropylcystene conjugates and derivatives and their uses in pharmaceutical compositions |
| 02/21/2012 | US8119642 Structurally rigid dopamine D3 receptor selective ligands and process for making them |
| 02/21/2012 | US8119102 Pharmaceutical composition of nanoparticles |
| 02/21/2012 | US8119101 Anti-CD74 immunoconjugates and methods of use |
| 02/16/2012 | WO2012021882A2 Formulation, apparatus and method for stabilizing radiopharmaceuticals |
| 02/16/2012 | WO2012021045A2 Sentinel lymph node marker capable of multi-mode imaging |
| 02/16/2012 | WO2011160216A3 Compounds useful in imaging and therapy |
| 02/16/2012 | WO2011143360A3 Compositions, methods and systems for the synthesis and use of imaging agents |
| 02/16/2012 | WO2011131693A3 Compositions and methods for selective delivery of oligonucleotide molecules to specific neuron types |
| 02/16/2012 | US20120042398 Compositions for labeling and identifying autophagosomes and methods for making and using them |
| 02/16/2012 | US20120041357 Method of controlled drug release from a liposome carrier |
| 02/16/2012 | US20120041303 Phage antibodies to radiation-inducible neoantigens |
| 02/16/2012 | US20120039803 Pretargeting kit, method and agents used therein |
| 02/16/2012 | US20120039802 Peptides that specifically bind hgf receptor (cmet) and uses thereof |
| 02/16/2012 | US20120039801 SPARC binding peptides and uses thereof |
| 02/16/2012 | US20120039800 Platinum Acridine Anti-Cancer Compounds And Methods Thereof |
| 02/16/2012 | US20120039799 Viral nanoparticle cell-targeted delivery platform |
| 02/16/2012 | US20120039798 Methods of modifying p53 acetylation and treating cancer using avra |
| 02/16/2012 | US20120039797 Antibody Therapy |
| 02/16/2012 | US20120039796 Novel method for creating, suspending and stabilizing electronically modified oxygen derivatives, along with creating, suspending and stabilizing electronically modified reaction intermediates, in a bio compatible fluorocarbon suspension, for the purpose of inducing a cascading immune response in mammalian patients |
| 02/15/2012 | EP2418220A2 Interferon alpha antibodies and their uses |
| 02/15/2012 | EP2418216A1 Molecular probe for imaging of pancreatic islet and precursor thereof, and use of the molecular probe or the precursor |
| 02/15/2012 | EP2416808A1 Imaging the central nervous system with purinergic p2x7 receptor binding agents |
| 02/15/2012 | EP2416807A1 Novel strategies for improved cancer vaccines |
| 02/15/2012 | EP2416806A1 Fucoidans as ligands for the diagnosis of degenerative pathologies |
| 02/15/2012 | EP2416788A2 Coupled identification and treatment of cancer |
| 02/15/2012 | EP1962868B1 Compositions and methods for preventing or reducing postoperative ileus and gastric stasis |
| 02/15/2012 | EP1309705B1 Multivalent target binding protein |
| 02/15/2012 | CN102356069A Radiolabelling reagents and methods |
| 02/15/2012 | CN102355899A Aryloxyanilide derivatives |
| 02/15/2012 | CN101678121B 对肿瘤细胞具有杀伤作用的改性羟基聚合物共轭物 Hydroxyl polymer-modified tumor cell killing effect of having a conjugate |
| 02/14/2012 | US8114965 Compositions of PSMA antibodies |
| 02/14/2012 | US8114431 Biomolecular coating for implants |
| 02/14/2012 | US8114381 Radiolabeled compounds and compositions, their precursors and methods for their production |
| 02/14/2012 | US8114380 Pharmaceutical composition of nanoparticles for protein drug delivery |
| 02/14/2012 | US8114379 Diagnostic and therapeutic alkyl piperidine/piperazine compounds and process |
| 02/14/2012 | CA2485339C Radiopharmaceutical formulations |
| 02/09/2012 | WO2012018790A2 Dual variable domain immunoglobulins and uses thereof |
| 02/09/2012 | WO2012018389A1 Artificial cells |
| 02/09/2012 | WO2012017891A1 Pyridyl benzofuran derivative |
| 02/09/2012 | WO2012017103A1 Transition metal-conjugated radiopharmaceuticals that can be used as therapeutic and/or diagnostic agents |
| 02/09/2012 | US20120035529 Tumor vascular marker-targeted vaccines |
| 02/09/2012 | US20120034165 Imaging the central nervous system with purinergic p2x7 receptor binding agents |
| 02/09/2012 | US20120034164 Truncated car peptides and methods and compositions using truncated car peptides |
| 02/09/2012 | US20120034163 Non-invasive tools for detecting vulnerable atherosclerotic plaques |
| 02/09/2012 | US20120034162 Fullerene Assisted Cell Penetrating Peptides |
| 02/09/2012 | US20120034161 Pretargeting kit, method and agents used therein |
| 02/09/2012 | US20120034160 Dual variable domain immunoglobulins and uses thereof |
| 02/09/2012 | US20120034159 Antibodies that bind both bcma and taci |
| 02/09/2012 | US20120034158 Anti-met monoclonal antibody, fragments and derivatives thereof for use in tumor diagnosis corresponding compositions and kits |